Clements, Caitlin C. http://orcid.org/0000-0003-2278-6465
Karlsson, Robert http://orcid.org/0000-0002-8949-2587
Lu, Yi
Juréus, Anders
Rück, Christian http://orcid.org/0000-0002-8742-0168
Andersson, Evelyn
Boberg, Julia
Pedersen, Nancy L.
Bulik, Cynthia M. http://orcid.org/0000-0001-7772-3264
Nordenskjöld, Axel
Pålsson, Erik
Sullivan, Patrick F. http://orcid.org/0000-0002-6619-873X
Landén, Mikael http://orcid.org/0000-0002-4496-6451
Funding for this research was provided by:
Stiftelsen för Strategisk Forskning (KF10-0039)
Svenska Forskningsrådet Formas (2018-02653, 2018-02487)
Fulbright Association
Forskningsrådet om Hälsa, Arbetsliv och Välfärd (2018-00221)
Vetenskapsrådet (D0886501)
EC | Horizon 2020 Framework Programme (COSYN, RIA grant agreement n° 610307)
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (U01 MH109528 and R01 MH077139)
Brain and Behavior Research Foundation
Article History
Received: 19 June 2020
Revised: 19 November 2020
Accepted: 2 December 2020
First Online: 22 January 2021
Compliance with ethical standards
:
: ML declares that, over the past 36 months, he has received lecture honoraria from Lundbeck pharmaceutical. PFS reports the following potentially competing financial interests. Current: Lundbeck (advisory committee, grant recipient), RBNC Therapeutics (advisory committee, stock ownership). CMB reports: Shire (grant recipient, Scientific Advisory Board member); Idorsia (consultant); Pearson (author, royalty recipient). AJ is currently employed at the Swedish Medical Products Agency, SE-75103 Uppsala, Sweden. The views expressed in this paper are the personal views of the authors and not necessarily the views of the government agency. AJ’s contribution to this work was done before he started his employment at the MPA.